This site provides INTERCEPT product information for International audiences Select your region
Switching from single to double dose buffy coat platelet prodcution by pooling 7 to 8 optimised buffy coats, may lower the number of buffy coats required to obtain 2 therapeutic doses. The usage of platelet pooling sets, platelet additive solution (PAS) and INTERCEPTTM processing sets can be reduced by 50%, and the number of sterile docks required can be reduced by up to 30%.
On top of these savings, the double dose buffy coat platelet production process can add logistical and economic advantages. Treating 2 therapeutic doses at once reduces the number of illuminations by 50%, equally saving on hands-on time. This, in turn, can translate into economic value.